Although TDP-43 is well studied in neurodegenerative diseases, it also has been demonstrated to promote aggressive triple-negative breast cancer, regulate mammary gland development as well as cancer-associated microRNAs (63–65). Here, TARDBP is linked to triple-negative breast carcinoma.